-
The Shigella Diarrhoea Prophylaxis Market Report For M&A, Expansion, And Competitive Benchmarking (2025–2034)
02 Jul 2025 13:21 GMT
… .com/report/shigella-diarrhoea-prophylaxis-global-market-report … bioconjugate shigellosis vaccines. These vaccines protect against four major Shigella serotypes … Market Segmentation Insights:
The shigella diarrhoea prophylaxis market is segmented …
-
CIDRZ Administers First Dose in Groundbreaking Shigella Vaccine Trial.
25 Jun 2025 18:14 GMT
… vaccine, a promising candidate against shigellosis, a severe diarrhoeal disease. The … effective, and accessible vaccine for shigellosis, a disease that disproportionately affects … in low-resource settings.
Shigellosis, caused by Shigella species, is a leading …
-
Second Shigella Vaccine Candidate May Protect Children from Diarrhea
18 Jun 2025 20:31 GMT
… antimicrobial-resistant enteric bacteria, including Shigella, highlights the broader impact a … Drug Administration (FDA)- approved Shigella vaccines.
Thomas Breuer, Chief … AG are co-developing the Shigella4V2 second-generation tetravalent bioconjugate vaccine …
-
Health Talk: Bharat Biotech-GSK’s Shigella vaccine candidate holds promise
14 Jun 2025 09:17 GMT
… this promising vaccine, targeting Shigellosis—a severe form of … . With no licensed Shigella vaccine currently available and … countries disproportionately impacted by Shigella, the development of … the development of our Shigella vaccine candidate, which has …
-
Bharat Biotech acquires licence for GSK’s Shigella vaccine development
13 Jun 2025 15:06 GMT
… -income countries disproportionately impacted by Shigella, the development of a low … available, the development of our Shigella vaccine candidate, which has demonstrated … around the world.”
Shigellosis, caused by Gram-negative Shigella, leads to severe …
-
Bharat Biotech to develop GSK’s Shigella vaccine
13 Jun 2025 03:36 GMT
… , an innovative vaccine candidate targeting Shigellosis—a severe form of bacterial … one of the most advanced Shigella vaccine candidates globally.
Currently, there … is no approved vaccine for Shigella, despite the rising threat of …
-
GSK Licenses Experimental Shigella Vaccine to Bharat Biotech for Global Health Deployment
12 Jun 2025 16:26 GMT
… partnership fast-tracks late-stage Shigella vaccine development to protect … individual disease prevention. Shigellosis, caused by various Shigella species, including S … Shigella vaccine design.
With no licensed vaccines currently available for shigellosis …
-
Bharat Biotech licenses GSK's Shigella under trial vaccine
12 Jun 2025 15:58 GMT
… trial candidate for Shigellosis (caused by the bacterium Shigella ) to advance further … -2-3, is a promising Shigella vaccine candidate, for continued clinical … to develop a next-generation Shigella vaccine candidate, for a severe …
-
Bharat Biotech in-licences GSK's Shigella vaccine candidate
12 Jun 2025 16:20 GMT
… ;s Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in …
-
Bharat Biotech to lead further development of GSK Shigella vaccine
12 Jun 2025 15:01 GMT
… of this vaccine, targeting Shigellosis—a severe form of … globally. With no licensed Shigella vaccine currently available and … countries disproportionately impacted by Shigella, the development of a … the development of our Shigella vaccine candidate which has …